Together, these results support the hypothesis that polyploidization drives HCC development, at least in the context of TP53 mutation, and that the nuclear ploidy spectrum can be used as a marker of HCC aggressiveness. This evidence concerns the gene TP53 and hepatocellular carcinoma.